Oleic acid‐bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation
Oleic acid‐bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation
复制标题
DOI:
10.1111/febs.16672
复制
发表时间:
2022-11
期刊:
影响因子:
--
通讯作者:
Banlanjo Umaru;Yoshiteru Kagawa;Yuki Ohsaki;Yijun Pan;Chuck T. Chen;Daniel K. Chen;T. Abe;S. K. Shil;Hirofumi Miyazaki;Shuhei Kobayashi;M. Maekawa;Yui Yamamoto;Tunyanat Wannakul;Shuhan Yang;R. Bazinet;Y. Owada
中科院分区:
文献类型:
--
作者:
Banlanjo Umaru;Yoshiteru Kagawa;Yuki Ohsaki;Yijun Pan;Chuck T. Chen;Daniel K. Chen;T. Abe;S. K. Shil;Hirofumi Miyazaki;Shuhei Kobayashi;M. Maekawa;Yui Yamamoto;Tunyanat Wannakul;Shuhan Yang;R. Bazinet;Y. Owada
Fatty acid‐binding protein 7 (FABP7), one of the fatty acid (FA) chaperones involved in the modulation of intracellular FA metabolism, is highly expressed in glioblastoma, and its expression is associated with decreased patients' prognosis. Previously, we demonstrated that FABP7 requires its binding partner to exert its function and that a mutation in the FA‐binding site of FABP7 affects tumour biology. Here, we explored the role of FA ligand binding for FABP7 function in tumour proliferation and examined the mechanism of FABP7 and ligand interaction in tumour biology. We discovered that among several FA treatment, oleic acid (OA) boosted cell proliferation of FABP7‐expressing cells. In turn, OA increased FABP7 nuclear localization, and the accumulation of FABP7–OA complex in the nucleus induced the formation of nuclear lipid droplet (nLD), as well as an increase in colocalization of nLD with promyelocytic leukaemia (PML) nuclear bodies. Furthermore, OA increased mRNA levels of proliferation‐related genes in FABP7‐expressing cells through histone acetylation. Interestingly, these OA‐boosted functions were abrogated in FABP7‐knockout cells and mutant FABP7‐overexpressing cells. Thus, our findings suggest that FABP7–OA intracellular interaction may modulate nLD formation and the epigenetic status thereby enhancing transcription of proliferation‐regulating genes, ultimately driving tumour cell proliferation.